Oklo (OKLO) Reports $81.6M Loss; $3B Cash at Q2 2026 End

In Q2 2026, Oklo (OKLO) reported a year-to-date net loss of $81.6 million and closed the quarter with $3 billion in cash and marketable securities. The company adjusted its 2026 operating cash-use outlook to $120 million–$150 million, up from a prior range of $80 million to $100 million. Capital spending forecasts were also raised to $400 million–$500 million from $350 million–$450 million. The Groves isotope reactor achieved first criticality, with expectations for initial revenue in early 2027 from the Idaho lab, signaling significant ongoing developments for stakeholders and investors.